If you want a clearer framework for using peptides intelligently, start with the Injury, Joint & Recovery Blueprint
Cancers Basel
This segment begins at 2:40
Symptoms of Dry Eye Syndrome include: Redness, stinging, or burning of the eyes A scratchy sensation in the eyes Light sensitivity The sensation of having a foreign body in the eyes Stringy mucus in or around the eyes Difficulty wearing contact lenses or driving at night Watery eyes Blurred vision Eye fatigue Dry eye syndrome may have several causes, including age, medical conditions such as diabetes, rheumatoid arthritis, thyroid disorders, and medications like antihistamines, decongestants, and blood pressure medications

Standard AOD-9604 Dosing Protocol Subcutaneous Injection Dosing: Beginner: 250 mcg per dose, once daily Intermediate: 300-400 mcg per dose, once daily or divided into two doses Advanced: 500 mcg per dose, once daily or 250 mcg twice daily Oral Administration Dosing (if using oral formulation): Standard: 1-2 mg per dose, once daily on empty stomach Higher protocols: Up to 5-10 mg daily, as studied in clinical trials Frequency: Once daily (morning preferred) or twice daily (morning and early afternoon) Timing: Best administered on an empty stomach, typically upon waking or before exercise Cycle Length: 12-16 weeks for initial assessment, with potential for longer protocols based on response Off Cycle: 4-8 weeks between cycles, though not strictly required based on current research Note: Start at the lower end of the dosing range to assess individual tolerance